<DOC>
	<DOCNO>NCT02568787</DOCNO>
	<brief_summary>The purpose study investigate effect Rice Bran Arabinoxylan Compound ( RBAC ) outcome variable person non-alcoholic fatty liver disease ( NAFLD ) . This nutritional supplement make water soluble extract rice bran partially hydrolyze action natural enzyme complex extract Shiitake mushroom .</brief_summary>
	<brief_title>The Effect RBAC Supplement ( BRM4 ) NAFLD</brief_title>
	<detailed_description>The purpose study investigate effect Rice Bran Arabinoxylan Compound ( RBAC ) outcome variable person non-alcoholic fatty liver disease ( NAFLD ) . This nutritional supplement make water soluble extract rice bran partially hydrolyze action natural enzyme complex extract Shiitake mushroom . Given micronutrient may important regulate immune system , investigator investigate impact RBAC follow variable among 20 adult ( 18+ year age ) diagnose NAFLD : 1. albumin 2 . 4-hydroxynonenal 3. lipid 4. liver enzyme ( alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) , alkaline phosphatase ( ALP ) 5. malondialdehyde 6. γ-glutamyltransferase 7. cytokine ( TNF-α , LT-α , IL-1α , IL-1β , IL-6 , TNF-RI , TNF-RII , IFN-γ , IL-12 , IL-2 , IL-15 , IL-8 , IL-4 , IL-5 , IL-17 , IL-23 , IL-10 , IL-13 , IL-18 ) 8. lymphocytes 9. platelet Specifically , subject participate 3-month , two-group , randomize intervention , one group ( n=10 ) take 1 gram/day RBAC group ( n=10 ) take placebo compare difference outcomes two group . The result study intended address multi-faceted physiological problem NAFLD patient test efficacy nutritional supplement intervention multiple outcome population .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>1 . Age 18 old 2 . Confirmed NAFLD diagnosis 3 . On stable medication regimen intervention 4 . Planning maintain current medication course intervention 5 . Willing blood drawn 6 . Previous nutritional supplement usage similar polysaccharide formula permit , current use must stop 2 week trial 7 . Interested participate dietary supplement study 8 . Willing follow recommendation participate study 9 . Willing consume food , alcohol , caffeine , stimulant ( amphetamine ) 12 hour assessment 10 . Able provide inform consent 1 . Currently enrol another research trial similar investigative nutritional therapy 2 . Known allergy rice , rice bran , mushroom , relate food product 3 . Any gastrointestinal disorder could lead uncertain absorption study supplement 4 . Taking lipidlowering agent prior 3 month study enrollment 5 . Currently take immunomodulatory medication , i.e. , interferon 6 . Currently take chemotherapeutic agent 7 . Severe anemia medical condition permit safe blood draw 8 . A bleed disorder 9 . A terminal illness 10 . Women pregnant attempt conception , especially presence history recurrent spontaneous abortion 11 . Currently undergo internal defibrillation , like implantable heart device 12 . Erratic , accelerate , mechanically control irregular heart rhythms 13 . Atrial fibrillation/flutter 14 . Atrioventricular block 15 . Recently dyes introduced bloodstream , methylene blue , indocyanine green , indigo carmine , fluorescein 16 . Any implanted electronic device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>NAFLD</keyword>
	<keyword>cytokine</keyword>
	<keyword>interleukin ( IL )</keyword>
	<keyword>interferon ( IFN )</keyword>
	<keyword>liver function test ( LFTS )</keyword>
	<keyword>nutrition</keyword>
	<keyword>bran arabinoxylan compound ( RBAC )</keyword>
	<keyword>tumor necrosis factor -- type I receptor ( TNF-RI )</keyword>
	<keyword>TNF-RII ( tumor necrosis factor -- type II receptor ( TNF-RII )</keyword>
</DOC>